title: Decrease in antibiotic use, an added benefit of PCVs.
authors.affiliation: Department of Health Policy, Vanderbilt University School of Medicine, 1500 21st Avenue South, The Village at Vanderbilt Suite 2600, Nashville, TN 37212, USA. Electronic address: carlos.grijalva@vanderbilt.edu.
authors.forename: Carlos G
authors.initials: CG
authors.lastname: Grijalva
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001426:Bacterial Proteins / Q000276:immunology*; D002352:Carrier Proteins / Q000276:immunology*; D005260:Female; D006801:Humans; D007072:Immunoglobulin D / Q000276:immunology*; D008074:Lipoproteins / Q000276:immunology*; D008297:Male; D010033:Otitis Media / Q000517:prevention & control*; D011008:Pneumococcal Infections / Q000517:prevention & control*; D022242:Pneumococcal Vaccines / Q000008:administration & dosage*
chemical_list: D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; D002352:Carrier Proteins; D007072:Immunoglobulin D; D008074:Lipoproteins; C547294:PHiD-CV vaccine; D022242:Pneumococcal Vaccines; C067989:glpQ protein, Haemophilus influenzae